Literature DB >> 9188611

Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients.

S Stoll-Becker1, R Repp, D Glebe, S Schaefer, J Kreuder, M Kann, F Lampert, W H Gerlich.   

Abstract

Hepatitis B virus (HBV) has been reported to exist in peripheral blood mononuclear cells (PBMC), but it is not clear whether it replicates there. A precondition for replication should be the formation of covalently closed viral DNA and transcription of all essential viral mRNAs. The mRNAs of HBV form a nested box with common 3' ends. In order to detect even low levels of potential replication, we developed a quantitative reverse transcription-PCR method for detection of a smaller HBV mRNA species in the presence of the larger ones. All three highly viremic patients tested so far had mRNAs for the large and the small surface proteins and the X protein of the virus within PBMC but not in the virus from their sera. Furthermore, we detected by PCR covalently closed viral DNA in their PBMC. These data suggest that HBV may be not only taken up but also replicated by mononuclear blood cells and that these cells may be an extrahepatic site of viral persistence. X mRNA was detected in the largest amount. Possibly, X protein interferes with functions of the mononuclear cells during the immune response against the virus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188611      PMCID: PMC191779          DOI: 10.1128/JVI.71.7.5399-5407.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Detection of transcriptionally active hepatitis B virus DNA in peripheral mononuclear blood cells after infection during immunosuppressive chemotherapy using the polymerase chain reaction.

Authors:  R Repp; A Mance; C Keller; S Rhiel; W H Gerlich; F Lampert
Journal:  Arch Virol Suppl       Date:  1992

2.  Detection of a hepatitis B virus variant with a truncated X gene and enhancer II.

Authors:  R Repp; C Keller; A Borkhardt; A Csecke; S Schaefer; W H Gerlich; F Lampert
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Hepatitis B virus replication patterns after orthotopic liver transplantation: de novo versus recurrent infection.

Authors:  D D Douglas; J Rakela; H F Taswell; R A Krom; R H Wiesner
Journal:  Transplant Proc       Date:  1993-04       Impact factor: 1.066

4.  Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line.

Authors:  X Lu; T M Block; W H Gerlich
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

5.  Phytohemagglutinin and concanavalin A activate hepatitis B virus in peripheral blood mononuclear cells of patients with chronic hepatitis B virus infection.

Authors:  P Bouffard; J P Lamelin; F Zoulim; D Lepot; C Trepo
Journal:  J Med Virol       Date:  1992-08       Impact factor: 2.327

6.  Hepatitis B virus infection in liver allografts.

Authors:  N Walker; R Apel; P Kerlin; M Horn; R Tinniswood; S Lynch; R Strong
Journal:  Am J Surg Pathol       Date:  1993-07       Impact factor: 6.394

Review 7.  Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis.

Authors:  F V Chisari
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

8.  Up-regulation of intercellular adhesion molecule 1 transcription by hepatitis B virus X protein.

Authors:  K Q Hu; C H Yu; J M Vierling
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

9.  Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation.

Authors:  M R Lucey; D M Graham; P Martin; A Di Bisceglie; S Rosenthal; J G Waggoner; R M Merion; D A Campbell; T T Nostrant; H D Appelman
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

10.  Genotyping by multiplex polymerase chain reaction for detection of endemic hepatitis B virus transmission.

Authors:  R Repp; S Rhiel; K H Heermann; S Schaefer; C Keller; P Ndumbe; F Lampert; W H Gerlich
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

View more
  23 in total

Review 1.  Immune escape by hepatitis B viruses.

Authors:  U Protzer; H Schaller
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

Review 2.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

3.  Impact of HBV replication in peripheral blood mononuclear cell on HBV intrauterine transmission.

Authors:  Xiaohong Shi; Xuefei Wang; Xixi Xu; Yongliang Feng; Shuzhen Li; Shuying Feng; Bo Wang; Suping Wang
Journal:  Front Med       Date:  2017-11-23       Impact factor: 4.592

4.  The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review.

Authors:  Fabrizio Marcucci; Enea Spada; Alfonso Mele; Carmelo Antonio Caserta; Alessandro Pulsoni
Journal:  Am J Blood Res       Date:  2012-01-01

Review 5.  Clinical relevance of hepatitis B virus variants.

Authors:  Shan Gao; Zhong-Ping Duan; Carla S Coffin
Journal:  World J Hepatol       Date:  2015-05-18

6.  Detection and sequence analysis of hepatitis B virus integration in peripheral blood mononuclear cells.

Authors:  T Laskus; M Radkowski; L F Wang; M Nowicki; J Rakela
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

7.  In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus.

Authors:  Y Y Lew; T I Michalak
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  Repeated passage of wild-type woodchuck hepatitis virus in lymphoid cells does not generate cell type-specific variants or alter virus infectivity.

Authors:  Patricia M Mulrooney-Cousins; Tomasz I Michalak
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

9.  Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver.

Authors:  Tomasz I Michalak; Patricia M Mulrooney; Carla S Coffin
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Inducible interleukin 32 (IL-32) exerts extensive antiviral function via selective stimulation of interferon λ1 (IFN-λ1).

Authors:  Yongkui Li; Jiajia Xie; Xiupeng Xu; Li Liu; Yushun Wan; Yingle Liu; Chengliang Zhu; Ying Zhu
Journal:  J Biol Chem       Date:  2013-05-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.